Vanguard Group Inc Citius Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 7,005,119 shares of CTXR stock, worth $3.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,005,119

Previous 6,900,230 1.52%

Holding current value

$3.57 Million

Previous $5.24 Million 20.21%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.6 - $0.9 $62,933 - $94,400	104,889 Added 1.52%	7,005,119 $6.3 Million
Q4 2023 Feb 14, 2024	BUY	$0.65 - $0.86 $47,274 - $62,547	72,730 Added 1.07%	6,900,230 $5.24 Million
Q3 2023 Nov 14, 2023	BUY	$0.65 - $1.25 $95,143 - $182,967	146,374 Added 2.19%	6,827,500 $4.64 Million
Q2 2023 Aug 14, 2023	BUY	$1.08 - $1.65 $676,941 - $1.03 Million	626,798 Added 10.35%	6,681,126 $8.02 Million
Q1 2023 May 15, 2023	BUY	$0.78 - $1.42 $31,434 - $57,227	40,301 Added 0.67%	6,054,328 $7.08 Million

Q4 2022 Feb 10, 2023	BUY	$0.79 - $1.23 $157,262 - $244,851	199,066 Added 3.42%	6,014,027 $4.75 Million
Q3 2022 Nov 14, 2022	BUY	$0.14 - $1.33 $11,144 - $105,868	79,600 Added 1.39%	5,814,961 $7.04 Million
Q2 2022 Aug 12, 2022	SELL	$0.88 - $1.87 $423,523 - $899,987	-481,277 Reduced 7.74%	5,735,361 $5.28 Million
Q1 2022 May 13, 2022	BUY	$1.38 - $1.89 $55,238 - $75,652	40,028 Added 0.65%	6,216,638 $11.1 Million
Q4 2021 Feb 14, 2022	BUY	$1.51 - $2.2 $601,469 - $876,312	398,324 Added 6.89%	6,176,610 $9.51 Million
Q3 2021 Nov 12, 2021	BUY	$1.74 - $2.6 $218,323 - $326,229	125,473 Added 2.22%	5,778,286 $11.7 Million
Q2 2021 Aug 13, 2021	BUY	$1.51 - $4.23 $8.54 Million - $23.9 Million	5,652,813 New	5,652,813 $19.7 Million

Others Institutions Holding CTXR

# of Institutions

Shares Held

26.8M

Call Options Held

Put Options Held

View Full List

About Citius Pharmaceuticals, Inc.

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $74.5M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

More about CTXR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Citius Pharmaceuticals, Inc. Transaction History